CORRECTION article

Front. Physiol., 31 August 2022

Sec. Cardiac Electrophysiology

Volume 13 - 2022 | https://doi.org/10.3389/fphys.2022.974151

Corrigendum: Phenotypic variability in iPSC-induced cardiomyocytes and cardiac fibroblasts carrying diverse LMNA mutations

  • 1. Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States

  • 2. Heart Institute, Department of Medicine (Division of Cardiovascular Sciences), Morsani College of Medicine, University of South Florida, Tampa, FL, United States

Article metrics

View details

1,3k

Views

721

Downloads

In the published article, there was an error in Figure 1 as published. In panel B, ALP staining pictures for R335Q and R377H were inadvertently mislabeled, which needs to be replaced. R335Q shows overlap with M1I, and R377H shows overlap with R541C. The corrected Figure 1 appears below.

FIGURE 1

FIGURE 1

Differentiation and characterization of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iCMs) and cardiac fibroblasts (iCFs). (A) Sanger sequencing validates the presence of the individual mutation. (B) Representative staining of iPSCs expressing pluripotency markers SOX2 (green) and TRA-1-60 (red), SSEA4 (green), OCT4 (red), and alkaline phosphatase. Nuclei were stained with DAPI (blue). (C) Schematic of cardiac differentiation using STEMdiff™ Cardiomyocyte Differentiation kit. (D) Immunostaining of cardiac troponin T positive cardiomyocytes. (E) Workflow to induce cardiac fibroblasts using small molecule-based protocols. (F) Immunostaining of cardiac fibroblast specific marker, vimentin. Scale bar, 100 μm.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

LMNA, dilated cardiomyopathy, induced pluripotent stem cell, cardiomyocytes, cardiac fibroblasts, connexin 43

Citation

Yang J, Argenziano MA, Burgos Angulo M, Bertalovitz A, Beidokhti MN and McDonald TV (2022) Corrigendum: Phenotypic variability in iPSC-induced cardiomyocytes and cardiac fibroblasts carrying diverse LMNA mutations. Front. Physiol. 13:974151. doi: 10.3389/fphys.2022.974151

Received

20 June 2022

Accepted

26 July 2022

Published

31 August 2022

Volume

13 - 2022

Edited and reviewed by

Xianming Lin, New York University, United States

Updates

Copyright

*Correspondence: Thomas V. McDonald,

This article was submitted to Cardiac Electrophysiology, a section of the journal Frontiers in Physiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics